针对TNFR2用于癌症免疫疗法:最近的进展和未来的方向
Linxue Li1, Ruiwei Ye1, Yingying Li1
1Shanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, 201908, China.
Journal of translational medicine
|September 2, 2024
概括
新的研究探讨瘤坏死因子受体2 (TNFR2) 作为有前途的癌症免疫治疗标. TNFR2抗体治疗显示出克服PD-1/CTLA-4抑制剂等当前治疗方法的局限性的潜力,特别是在难以治疗的瘤中.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 癌症仍然是全球主要的死亡原因,目前的免疫疗法如PD-1/CTLA-4抑制剂具有显著的局限性.
- 这些局限性包括高免疫相关的不良事件和对具有免疫抑制微环境的"冷"瘤的无效.
研究的目的:
- 审查瘤坏死因子受体2 (TNFR2) 治疗的特征,功能和最近的进展.
- 突出TNFR2作为下一代抗癌疗法的新目标.
主要方法:
- 审查临床前研究和有关TNFR2的现有文献.
- 分析TNFR2在瘤细胞增殖和Treg细胞介导免疫抑制中的作用.
- 评估TNFR2抗体治疗的疗效,无论是单一治疗还是与PD-1/CTLA-4抑制剂结合使用.
主要成果:
- TNFR2促进瘤细胞增殖,并与抑制Treg细胞功能相关,有助于免疫抑制瘤微环境.
- 临床前研究表明,TNFR2抗体治疗证明了作为独立治疗的有效性.
- 当与PD-1/CTLA-4抑制剂相结合时,TNFR2抗体疗法显示出潜在的协同效应.
结论:
- TNFR2是癌症免疫治疗的有前途的新目标.
- TNFR2抗体疗法为当前免疫疗法提供了潜在的替代或补充方法,解决了它们的局限性.
- 对TNFR2治疗的进一步研究可能会导致更有效的癌症治疗方法,特别是对于耐药瘤.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861